Genetic Polymorphisms of Endothelial Nitric Oxide Synthase Associated with Hypertension and Blood Homocysteine Levels
Charinya Chaichanabut,Piyamitr Sritara,Jintana Sirivarasai
DOI: https://doi.org/10.2147/ijgm.s456519
IF: 2.145
2024-04-21
International Journal of General Medicine
Abstract:Charinya Chaichanabut, 1 Piyamitr Sritara, 2 Jintana Sirivarasai 3 1 Master of Science Program in Nutrition, Faculty of Medicine Ramathibodi Hospital and Institute of Nutrition, Mahidol University, Bangkok, Thailand; 2 Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 3 Nutrition Unit, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Correspondence: Jintana Sirivarasai, Nutrition Unit, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand, Tel +662-201-1483, Fax +662-201-2625, Email Purpose: Endothelial dysfunction is a key mechanism in the development of hypertension and is closely linked to impairment of endothelial nitric oxide synthase (eNOS) and hyperhomocysteinemia. Genetic polymorphisms of eNOS (rs1799983 and rs2070744) are strongly associated with the risk of hypertension in individuals of Asian ethnicities. This study aimed to investigate the relationship between these polymorphisms and the risk of hypertension associated with homocysteine levels. Participants and Methods: For this cross-sectional study, we enrolled 370 Thai men aged 40– 60 years from the Electricity Generating Authority of Thailand cohort study for both variants genotyping by TaqMan allelic discrimination analysis. Clinical, anthropometric, and biochemical parameters were also analyzed. Results: In the high blood pressure group (n = 267), systolic and diastolic blood pressure and triglyceride levels were higher in those with homocysteine levels ≥ 15 μmol/L than in those with homocysteine levels < 15 μmol/L (p < 0.05). Significant risk of hypertension was found in GG and GT of rs1799983 (G894T), and in TT and TC of rs2070744 (T-786C), with higher ORs in heterozygous genotypes (all p values < 0.05). Further evaluation of the interactions between SNPs and HCY revealed that individuals with the GT or TC genotype, together with hyperhomocysteinemia, had an increased risk of hypertension (all p< 0.05). Conclusion: eNOS variants rs1799983 and rs2070744 may be risk factors for hypertension linked to hyperhomocysteinemia. These findings provide potentially useful healthcare strategies for the management of hypertension. Keywords: endothelial nitric oxide synthase, polymorphisms, hypertension, hyperhomocysteinemia The global prevalence of hypertension has increased dramatically over the past two decades. The World Health Organization reported that in 2020, an estimated 1.28 billion adults aged 30–79 years worldwide had hypertension, two-thirds of whom were living in low- and middle-income countries. 1 A cross-sectional study investigated the behavioral and metabolic risk factors for noncommunicable diseases based on an analysis of a survey conducted among 2311 adults (≥18 years). The results showed that the prevalence of metabolic risk factors, including age, smoking, alcohol consumption, and work status, was more pronounced in men and was related to high blood pressure, overweight and obesity, cholesterol level, and blood glucose level. 2 In the Thailand National Health Security Office program, the prevalence of hypertension among men was found to be 37.8%, of which 23.9% of cases were uncontrolled. 3 Established mechanisms associated with the development of hypertension include hyperhomocysteinemia (plasma concentration ≥ 15 μmol/L), which is recognized as a risk factor for cardiovascular diseases including the onset of hypertension. 4 The proposed mechanisms involve homocysteine (HCY)-induced vascular damage, including increased smooth muscle cell proliferation, stimulated oxidation of the vascular endothelium, decreased vascular elasticity, and increased sodium reabsorption. 5 The current study among patients with newly diagnosed primary hypertension reported an association between plasma total homocysteine levels and systolic blood pressure (SBP) (r = 0.696), diastolic blood pressure (DBP) (r=0.585), and age (r= 0.286). 6 A cross-sectional study of 2615 Chinese people discovered that higher HCY levels were substantially linked to hypertension risk and influenced by interactions with age, obesity, dyslipidemia, and family history of the condition (all p < 0.05). 7 Impairment of nitric oxide (NO) bioavailability can lead to endothelial dysfunction, which is a significant risk factor for hypertension. NO production is based on the function of endothelial NO synthase (eNOS or NOS3), which metabolizes l-arginine to NO. Decreased NO production promotes an imbalance in vascular homeostasis, leading to prothrombotic, proinflammatory, and less compliant blood vessel walls. 8,9 Consequently -Abstract Truncated-
medicine, general & internal